Impact of Sarcopenia and Pretreatment Skeletal Muscle Loss on Survival in Endometrial Cancer Patients Treated With Immune Checkpoint Inhibitors.

J Obstet Gynaecol Res · 2026 · PMC13249536 · PMID 42264544

Europe PMC DOI

hedged sentences

0.4400

closest p · 8.8× alpha

0.4400

boldest claim

The sentences

did not reach statistical significancep = 0.44not close (p > 0.1)

In the nonsarcopenia group, patients with greater SMI loss tended to have poorer survival, although the results did not reach statistical significance: PFS (log‐rank p = 0.44) and OS (log‐rank p = 0.14).

also in 111,027 other papers

showed a trendno p-value reported

Results Ten patients (50%) were sarcopenic at ICI initiation and showed a trend toward poorer progression‐free survival (PFS) and overall survival (OS).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.